BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Biocure Technology Inc. Announces Focus on its own CAR T-cell Therapy Targeting Chronic Lymphocytic Leukemia (“CLL”) and Solid Tumor Cancers and Intent to Apply for Patents

  BPK is using an innovative concept of ROR1 CAR T-cell therapy combined with a double specific antibody model. In conjunction with the development of it’s own CAR T, the Company plans to apply for patents covering this CAR T-cell cancer therapy technology.

  August 30, 2021

   · 

  4 min read
• Business

  Gemina Labs Announces Research and Development Appointments

  Gemina Laboratories Ltd. (CSE:GLAB) (the “Company” or “Gemina”) is pleased to announce several key hires within our Research and Development team.

  August 30, 2021

   · 

  4 min read
• Business

  Samyang Biopharm USA, Inc. and Spanish National Research Council (CSIC) Announce Strategic Collaboration to Study SYB-010; A First-in-Class, Immune Stimulatory Monoclonal Antibody

  Samyang Biopharm USA, Inc. and Spanish National Research Council (CSIC) Announce Strategic Collaboration to Study SYB-010; A First-in-Class, Immune Stimulatory Monoclonal Antibody

  August 30, 2021

   · 

  3 min read
• Business

  Xeris Pharmaceuticals Announces Leading Independent Proxy Advisory Firm, ISS, Recommends Xeris Stockholders Vote “FOR” the Transaction With Strongbridge Biopharma

  Xeris Pharmaceuticals, Inc. (Nasdaq: XERS) today announced that a leading independent proxy advisory firm Institutional Shareholder Services (“ISS”) has recommended that Xeris stockholders vote “FOR” all proposals related to the Company’s transaction with Strongbridge Biopharma plc

  August 30, 2021

   · 

  8 min read
• Business

  Eisai Announces New Executive Leadership Team at H3 Biomedicine

  Eisai today announced that H3 Biomedicine (H3), its cancer genomics-based drug discovery subsidiary company located in Cambridge, Mass. , has appointed a new executive leadership team.

  August 30, 2021

   · 

  4 min read
• Business

  Galectin Therapeutics Strengthens Leadership Team with Strategic Hires to Advance Programs in Cancer Immunotherapy and NASH Cirrhosis

  Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that the Company has recently expanded its management team with multiple key leadership appointments,

  August 30, 2021

   · 

  8 min read
• Business

  Portage Biotech Announces Results for First Quarter of 2022 Fiscal Year

  Portage Biotech Inc. today announced financial results for the quarter ended June 30, 2021.

  August 30, 2021

   · 

  10 min read
• Business

  Kaiser Permanente Bernard J. Tyson School of Medicine Announces New Assistant Dean for Community Engagement

  The Kaiser Permanente Bernard J. Tyson School of Medicine today announced the naming of Lori Carter-Edwards , PhD, MPH as Assistant Dean for Community Engagement.

  August 30, 2021

   · 

  3 min read
• Business

  Boundless Bio Appoints Jessica Oien as General Counsel and Corporate Secretary

  Boundless Bio today announced that it has appointed Jessica Oien as General Counsel and Corporate Secretary.

  August 30, 2021

   · 

  2 min read
• Business

  Covalon Announces Fiscal 2021 Q3 Results

  Covalon Technologies Ltd. today announced its fiscal 2021 third quarter results for the period ended June 30 , 2021.

  August 30, 2021

   · 

  12 min read